Alm Servicos De Oftalmologia Medica E Cirurgica S.A.
- Address
- lock Available on a paid plan
ALM Serviços de Oftalmologia Médica e Cirúrgica S.A.
ALM Serviços de Oftalmologia Médica e Cirúrgica S.A. is a specialized ophthalmology research center with particular expertise in retinal vascular diseases and advanced medical and surgical eye care. The center demonstrates significant capabilities in conducting complex clinical investigations focused on vision-threatening macular conditions.
- Polypoidal choroidal vasculopathy (PCV) treatment and management
- Intravitreal injection therapies and novel anti-VEGF agents
- Best corrected visual acuity outcomes research in retinal disorders
The center is actively involved in Phase IV clinical trials evaluating innovative therapeutic approaches for symptomatic macular polypoidal choroidal vasculopathy, with particular focus on emerging biologic treatments such as faricimab. Their research contributes to understanding the efficacy, safety, and durability of next-generation therapies in Caucasian patient populations, addressing critical gaps in the management of complex retinal vascular pathologies.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 84 other sites in Portugal
Therapeutic Area Benchmark — Portugal
Select a therapeutic area to compare against other sites in Portugal.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Portugal
Market Share
Country: Portugal
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Alm Servicos De Oftalmologia Medica E Cirurgica S.A.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy, Safety, and Durability of Faricimab in Caucasian Patients with Polypoidal Choroidal Vasculopathy: A Phase IV, Multicentre, Open-Label Study | Association For Innovation And Biomedical Research On Light And Image | Phase III | Recruiting | Aug 2025 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Faricimab | 1 | Unknown | 2025-08-06 | 2025-08-06 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.